These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38639689)

  • 1. Evaluation of the REDUCE-CLOT Study.
    Shlofmitz E; Garcia-Garcia HM; Chau K; Dakroub A; Thomas SV; Busch J; Ali ZA; Jeremias A; Shlofmitz R; Waksman R
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1410-1412. PubMed ID: 38639689
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual antiplatelet therapy in acute coronary syndrome after stent implantation: How short is short and how long is long?
    Tsioufis C
    Hellenic J Cardiol; 2018; 59(6):376-377. PubMed ID: 30682418
    [No Abstract]   [Full Text] [Related]  

  • 3. ISAR-REACT 5 - What have we learned?
    Kubica J; Jaguszewski M
    Cardiol J; 2019; 26(5):427-428. PubMed ID: 31536136
    [No Abstract]   [Full Text] [Related]  

  • 4. Prasugrel vs. ticagrelor after acute coronary syndrome: a critical appraisal of the ISAR-REACT 5 trial.
    Sulzgruber P; Niessner A
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):273-274. PubMed ID: 31865384
    [No Abstract]   [Full Text] [Related]  

  • 5. Ticagrelor monotherapy in patients with diabetes mellitus undergoing percutaneous coronary interventions: insights from the TWILIGHT trial.
    Angiolillo DJ; Baber U; Mehran R
    Cardiovasc Res; 2020 Jun; 116(7):e70-e72. PubMed ID: 32406492
    [No Abstract]   [Full Text] [Related]  

  • 6. DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients.
    Montalto C; Ferlini M; Casula M; Mandurino-Mirizzi A; Costa F; Leonardi S; Oltrona Visconti L
    Thromb Haemost; 2021 May; 121(5):687-689. PubMed ID: 33212543
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
    Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions.
    Neupane S; Khawaja O; Edla S; Singh H; Othman H; Bossone E; Yamasaki H; Rosman HS; Eggebrecht H; Mehta RH
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):98-104. PubMed ID: 30585391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials.
    Yu J; Mehran R; Clayton T; Gibson CM; Brodie BR; Witzenbichler B; Lincoff AM; Deliargyris EN; Gersh BJ; Pocock SJ; Stone GW; Dangas GD
    Catheter Cardiovasc Interv; 2016 Feb; 87(3):391-400. PubMed ID: 26624854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients.
    Kandzari DE; Kirtane AJ; Windecker S; Latib A; Kedhi E; Mehran R; Price MJ; Abizaid A; Simon DI; Worthley SG; Zaman A; Choi JW; Caputo R; Kanitkar M; McLaurin B; Potluri S; Smith T; Spriggs D; Tolleson T; Nazif T; Parke M; Lee LC; Lung TH; Stone GW;
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e009565. PubMed ID: 33167705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Anticoagulants With Dual Antiplatelet Therapy Versus Clopidogrel in Patients After Percutaneous Coronary Intervention: A Meta-Analysis.
    Palla M; Briasoulis A; Kondur A
    Am J Ther; 2019; 26(1):e143-e150. PubMed ID: 27340910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian Analysis: A Practical Approach to Interpret Clinical Trials and Create Clinical Practice Guidelines.
    Bittl JA; He Y
    Circ Cardiovasc Qual Outcomes; 2017 Aug; 10(8):. PubMed ID: 28798016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of antiplatelet regimens after percutaneous coronary intervention using drug eluting stents: A network meta-analysis of randomized controlled trials.
    Garg A; Rout A; Sharma A; Sargsyan D; Beavers T; Tantry U; Gurbel P; Rao SV; Kostis JB; Cohen M
    Prog Cardiovasc Dis; 2020; 63(3):243-248. PubMed ID: 32247786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention.
    Al Said S; Katus HA; Alabed S
    Heart; 2020 Sep; 106(17):1293-1295. PubMed ID: 32471906
    [No Abstract]   [Full Text] [Related]  

  • 15. Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention.
    Wang TY; McCoy L; Henry TD; Effron MB; Messenger JC; Cohen DJ; Mark DB; Stone GW; Zettler M; Singh M; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2014 Apr; 63(16):1700-2. PubMed ID: 24486275
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct Xa inhibitors in addition to antiplatelet therapy in acute coronary syndrome: meta-analysis of randomized trials.
    Villablanca PA; Holmes D; Mohananey D; Briceno DF; Núñez Gil IJ; Kargoli F; Gupta T; Kizer JR; Bortnick AE; Wiley J; Menegus MA; Pyo R; García M; Ramakrishna H; Mookadam F
    Coron Artery Dis; 2017 Aug; 28(5):395-405. PubMed ID: 28328784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention.
    Kreutz RP; Schmeisser G; Maatman B; Schaffter A; Sinha A; von der Lohe E; Breall JA
    Thromb Haemost; 2017 Jan; 117(2):426-428. PubMed ID: 27808346
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronary intervention in 2015: Improvement of long-term outcomes after PCI.
    Zeymer U
    Nat Rev Cardiol; 2016 Feb; 13(2):69-70. PubMed ID: 26763540
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual therapy with direct oral anticoagulants significantly increases the risk of stent thrombosis compared to triple therapy.
    Galli M; Andreotti F; D'Amario D; Vergallo R; Montone RA; Porto I; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):128-129. PubMed ID: 31309231
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials.
    Ziada KM; Abdel-Latif AK; Charnigo R; Moliterno DJ
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):722-732. PubMed ID: 26309050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.